Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas-Reference-Cited by-同舟云学术

Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas

Published:1995-01 Issue:5 Volume:31 Page:782-784
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Phillips M.B.,Flamant F.,Sommelet-Olive D.,Pinkerton C.R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. The intergroup rhabdomyosarcoma study—II;Maurer;Cancer,1993

2. Assessing the benefit of primary chemotherapy in the treatment of rhabdomyosarcoma in children. Report from the International Society of Pediatric Oncology: RMS 84 study;Flamant,1991

3. Treatment of soft tissue sarcoma in childhood and adolescence;Koscielniak;Cancer,1992

4. Review of etoposide single agent activity;Schmoll;Cancer Treat Rev,1982

5. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group report;Chard;Cancer Treat Rep,1979

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours;European Journal of Cancer;2007-09

2. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults;Pediatric Blood & Cancer;2005-07

3. Ten-Day Schedule Oral Etoposide Therapy in Advanced Childhood Malignancies;Journal of Pediatric Hematology/Oncology;2000-03

4. Phase II study of 21 day schedule oral etoposide in children;European Journal of Cancer;1997-10

5. A Feasibility, Toxicity, and Early Response Study of Etoposide, Ifosfamide, and Vincristine for the Treatment of Children with Rhabdomyosarcoma: A Report from the Intergroup Rhabdomyosarcoma Study (IRS) IV Pilot Study;Journal of Pediatric Hematology/Oncology;1997-03